PURPOSE: To evaluate the efficacy and safety of monthly intravitreal injections of ranibizumab in patients with polypoidal choroidal vasculopathy (PCV) and active exudation or hemorrhage. METHODS: A prospective, single practice, open label trial of monthly intravitreal ranibizumab (0.5 mg) injection...
No comments yet
Be the first to share your thoughts!